Trending...
- The Finger Comb, a Dream Inspired 3-in-1 Styling Tool introduced by Andrea L. Randolph
- Bishop Mary's WWDB 860 AM Show Nears Historic 250-Episode Milestone
- Dog Grooming Businesses Turn to Performance-Based Platforms to Attract Local Clients
PHILADELPHIA, Oct. 22, 2024 ~ A recent study conducted by researchers at Children's Hospital of Philadelphia (CHOP) has shown the potential for rapid testing of cytokine levels to aid in distinguishing between different diseases with similar symptoms. The findings, published in the Journal of Allergy and Clinical Immunology, demonstrate the impact this testing can have on clinical practice.
The study, led by Dr. Michele P. Lambert, Medical Director of the Special Coagulation Laboratory and attending physician in the Division of Hematology at CHOP, focused on the use of serum cytokine panels in pediatric clinical practice. Cytokines are signaling proteins that regulate inflammation and coordinate immune responses.
During the COVID-19 pandemic, doctors faced a challenge in distinguishing between multisystem inflammatory syndrome in children (MIS-C) and acute, severe COVID-19 infection. Both conditions present with similar initial symptoms such as high fever and changes in blood pressure, but require very different courses of treatment.
Dr. Lambert explains, "We wanted to see what clinicians were able to do with this information if it was returned rapidly and whether results would change clinical decision making or muddy the waters and create confusion."
More on The PennZone
The study found that nearly 30% of clinicians changed how they managed disease in children after receiving cytokine level information. In 18.8% of cases, the diagnosis was changed or informed by the results, while management of the patient was changed or informed in 29.8% of cases.
One key finding was that specific disease states had clear cytokine patterns. For example, higher levels of interferon gamma (IFNg) and lower levels of interleukins 6 and 8 (IL-6 and IL-8) suggested a more robust inflammatory response, while a reverse in those levels indicated bacterial or viral sepsis.
Dr. Lambert emphasizes the potential life-saving impact of these results: "The results of a cytokine panel could potentially save lives: supporting antibiotics or immune suppression, but only if we have the results fast enough."
The study also highlights the importance of collaboration between clinicians and clinical laboratories in providing the best care for patients. As Dr. Lambert notes, "The evolution of our response time and our understanding of the value of these biomarkers demonstrates how important it is for clinicians and clinical laboratories to collaborate to provide the best care possible for patients."
With ongoing advancements in technology and understanding, rapid testing of cytokine levels has the potential to greatly impact clinical practice and improve patient outcomes. The study, titled "Serum Cytokine Panels in Pediatric Clinical Practice," was published online on September 18, 2024, with a DOI of 10.1016/j.jaci.2024.08.030.
For further information or inquiries, please contact Amanda DiPaolo Bradley at [insert contact information].
The study, led by Dr. Michele P. Lambert, Medical Director of the Special Coagulation Laboratory and attending physician in the Division of Hematology at CHOP, focused on the use of serum cytokine panels in pediatric clinical practice. Cytokines are signaling proteins that regulate inflammation and coordinate immune responses.
During the COVID-19 pandemic, doctors faced a challenge in distinguishing between multisystem inflammatory syndrome in children (MIS-C) and acute, severe COVID-19 infection. Both conditions present with similar initial symptoms such as high fever and changes in blood pressure, but require very different courses of treatment.
Dr. Lambert explains, "We wanted to see what clinicians were able to do with this information if it was returned rapidly and whether results would change clinical decision making or muddy the waters and create confusion."
More on The PennZone
- Free PDF Tools Online: Edit, Convert, Compress, Merge and Manage PDF Files in One Platform
- Evermore Bliss Launches AI Wedding Speech Writer to Help Users Create Personalized, Heartfelt Toasts
- Keenethics enters the ChatGPT Apps ecosystem as a new growth opportunity for businesses
- Spring Into Your New Home at Heritage at South Brunswick
- ULiveUSA Launches New "Moment Marketing" System Using Videos to Help Local Businesses Get More Customers
The study found that nearly 30% of clinicians changed how they managed disease in children after receiving cytokine level information. In 18.8% of cases, the diagnosis was changed or informed by the results, while management of the patient was changed or informed in 29.8% of cases.
One key finding was that specific disease states had clear cytokine patterns. For example, higher levels of interferon gamma (IFNg) and lower levels of interleukins 6 and 8 (IL-6 and IL-8) suggested a more robust inflammatory response, while a reverse in those levels indicated bacterial or viral sepsis.
Dr. Lambert emphasizes the potential life-saving impact of these results: "The results of a cytokine panel could potentially save lives: supporting antibiotics or immune suppression, but only if we have the results fast enough."
The study also highlights the importance of collaboration between clinicians and clinical laboratories in providing the best care for patients. As Dr. Lambert notes, "The evolution of our response time and our understanding of the value of these biomarkers demonstrates how important it is for clinicians and clinical laboratories to collaborate to provide the best care possible for patients."
With ongoing advancements in technology and understanding, rapid testing of cytokine levels has the potential to greatly impact clinical practice and improve patient outcomes. The study, titled "Serum Cytokine Panels in Pediatric Clinical Practice," was published online on September 18, 2024, with a DOI of 10.1016/j.jaci.2024.08.030.
For further information or inquiries, please contact Amanda DiPaolo Bradley at [insert contact information].
Filed Under: Business
0 Comments
Latest on The PennZone
- Additions of Tennant, Morrissey, Cummings, Hale Highlight Fandoms at FAN EXPO Philadelphia
- GitKraken Desktop 12.0 Introduces Agent Mode: Gives Developers Ultimate Control & Visualization While Scaling Parallel Agent Workflows
- 5 Things to Check Before Calling for AC Repair in Philly
- Go Dental Clinic Announces Upcoming Opening of New Branch in International City, Dubai
- Dog Grooming Businesses Turn to Performance-Based Platforms to Attract Local Clients
- Hazel E Hosts Starline Tours Bus to Sonic Desert - A Launch to Coachella
- Best Companies Group Launches Free Top Companies to Work for in Arizona Program
- A Powerful Beginning Inside One of Philadelphia's Most Inspiring Early Childhood Education Centers
- A1 OM Ads LLC Expands Platform With AI Tools And Digital Marketing Solutions
- Streater Appointed to Judicial Commission of the Philadelphia Bar Association
- Contracting Resources Group and Aalis Management Consulting Launch ARG Joint Venture Under SBA Mentor-Protégé Program
- Space Opera Debut Earns Prometheus Award Nomination
- Card makers turn to Pink and Main for tools to support their craft
- Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
- EduCare Inc. Bridges Critical Gap in Breast Cancer Education with Spanish COPE Library Launch
- Engineering leaders from industry, academia to gather at IISE Annual Conference & Expo in Arlington, Texas
- AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
- BestDoc Launches AI Call Center for Healthcare
- Authentise Launches "Whisper," Agentic AI Backbone for Engineering & Manufacturing
- Old Economy Village Invites Visitors to Explore its 2026 Event Season